Dr. Reddy's Laboratories Ltd Common Stock vs TD SYNNEX Corporation Common Stock — how do they compare? Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B), while TD SYNNEX Corporation Common Stock trades at $258.65 (market cap $22.02B). The key difference: TD SYNNEX Corporation Common Stock is far larger — about 2× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and TD SYNNEX Corporation Common Stock pays the higher dividend (0.7%). Which is the better fit depends on your goals — on Pluang, investors hold Dr. Reddy's Laboratories Ltd Common Stock for 0 Days and TD SYNNEX Corporation Common Stock for 0 Days on average.
| RDY | SNX | |
|---|---|---|
Market Cap | $10.78B | $22.02B |
Volume | 2,724,343 | 614,208 |
Sector | Health | Technology |
52-Week High | $15.38 | $290.14 |
52-Week Low | $11.38 | $142.42 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.68B | $26.79B |
Dividend Yield | 0.65% | 0.7% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →TD SYNNEX Corporation is a global IT distributor and solutions aggregator that distributes endpoint devices and data-center technologies from technology vendors to resellers and customers worldwide.
Read more on SNX →